Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral midazolam for anxiety, distress, and pain during port needle placement in children with cancer
2004-002378-42Phase 3Completed
- Sponsor
- Department of Pediatric Hematology
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in cancer comparing Dormicum + EMLA with Placebo + EMLA (2 arms). Primary endpoint: Fear. Started Dec 2004; status: completed.
02
Drugs
midazolam
03
Conditions
cancer
Beyond the preview
Go deeper on 2004-002378-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002378-42.